BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

• Status: Terminated
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is to observe the long-term treatment of BG9924

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Biogen
• Treatments: Methotrexate

Criteria

Inclusion Criteria:

• Must be a participant from Study 104RA203 (NCT 00458861)

Exclusion Criteria:

• Participants with a significant change in medical history from their previous BG9924 Study 104RA203 (NCT 00458861).

• Nursing mothers, pregnant women, or women who are planning to become pregnant while in the study.

• Male and female participants of child-bearing potential not willing to practice effective birth control for the duration of the study.

NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.